DT
HealthMore in Health→
Tirzepatide Linked to Lower Risk of Diabetic Eye Disease in Large Study
Key Takeaways
- A Weill Cornell study of 174,000 patients finds tirzepatide users have roughly 60% lower risk of diabetic retinopathy
- Benefits extended to advanced disease forms including proliferative retinopathy, macular edema, and vitreous hemorrhage
- Tirzepatide users also needed fewer eye interventions, suggesting the drug protects vision beyond glucose control alone
DE
DT Editorial Team··3 min read·via medicalxpress.com